Valuation: Eckert & Ziegler SE

Market Cap 857M 976M 798M 734M 1.38B 93.26B 1.4B 9.46B 3.7B 46.25B 3.66B 3.59B 160B P/E 2026 *
16.5x
P/E 2027 * 15.5x
Enterprise Value 741M 844M 690M 634M 1.19B 80.62B 1.21B 8.18B 3.2B 39.98B 3.17B 3.1B 138B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.15x
Free-Float
67.36%
Yield 2026 *
1.42%
Yield 2027 * 1.46%
1 day+0.15%
1 week-5.36%
Current month-12.43%
1 month-11.71%
3 months-10.83%
6 months-13.66%
Current year-11.83%
1 week 13.11
Extreme 13.11
14.1
1 month 13.11
Extreme 13.11
16.14
Current year 13.11
Extreme 13.11
16.82
1 year 13.11
Extreme 13.11
22.77
3 years 9.67
Extreme 9.6667
23.07
5 years 9.67
Extreme 9.6667
46.92
10 years 1.73
Extreme 1.7287
46.92
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-5.36% - - 976M
+3.78%+2.39%+15.86%-39.35% 15.69B
+1.77%+9.36%-0.04%+98.18% 1.74B
-0.95%+1.46%-36.11%-80.87% 1.14B
+0.28%+0.38%-45.34%-54.13% 633M
+1.36%+0.15%-47.70%-57.13% 517M
+1.37%+3.82%+40.89%-51.71% 470M
+1.31%-0.32%-56.18%-60.88% 376M
+1.83%-0.28%-20.04%-34.81% 355M
-8.97%-12.64%+32.42% - 289M
Average +0.19%+0.55%-12.92%-35.09% 2.36B
Weighted average by Cap. +2.77%+2.43%+7.30%-31.61%

Financials

2026 *2027 *
Net sales 319M 363M 297M 273M 512M 34.69B 520M 3.52B 1.38B 17.2B 1.36B 1.33B 59.44B 340M 388M 317M 292M 547M 37.06B 556M 3.76B 1.47B 18.38B 1.46B 1.43B 63.51B
Net income 51.68M 58.89M 48.12M 44.26M 82.98M 5.63B 84.4M 571M 223M 2.79B 221M 216M 9.64B 53.08M 60.49M 49.43M 45.47M 85.23M 5.78B 86.69M 586M 230M 2.87B 227M 222M 9.9B
Net Debt -116M -132M -108M -99.44M -186M -12.64B -190M -1.28B -502M -6.27B -497M -486M -21.66B -126M -143M -117M -107M -202M -13.66B -205M -1.39B -543M -6.78B -537M -525M -23.41B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
26-07-28 €13.50 -0.15% 463
26-07-27 €13.52 +2.19% 164,278
26-07-24 €13.23 -1.05% 2,025
26-07-23 €13.37 -5.65% 1,089
26-07-22 €14.17 -0.07% 96
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.69EUR
Average target price
21.60EUR
Spread / Average Target
+57.78%

Quarterly revenue - Rate of surprise